Arturo Anadón Selected Research

Arturo Anadón Research Topics

Disease

8	Body Weight (Weight, Body) 10/2018 - 11/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 11/2022
3	Neoplasms (Cancer) 06/2023 - 01/2020
3	Necrosis 03/2020 - 11/2017
3	Neuroblastoma 01/2020 - 05/2017
2	Obesity 10/2023 - 01/2021
2	Poisoning 01/2022 - 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Insulin Resistance 10/2023
1	Carcinogenesis 10/2023
1	Autoimmune Diseases (Autoimmune Disease) 04/2023
1	Inflammation (Inflammations) 05/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Carcinoma (Carcinomatosis) 11/2020
1	Growth Disorders 01/2020
1	Hepatitis B 01/2020
1	Muscular Diseases (Myopathy) 01/2019
1	Weight Loss (Weight Reduction) 06/2018
1	Infections 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2021
3	Pyrethrins (Pyrethroids)FDA Link 11/2022 - 03/2020
3	cyfluthrinIBA 03/2020 - 08/2018
2	AntioxidantsIBA 10/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023 - 03/2020
2	cypermethrin (alphamethrin)IBA 03/2020 - 05/2017
1	2,3,5,6-tetrafluoro-4-methylbenzyl (Z)- (1RS)- cis- 3- (2- chloro- 3,3,3- trifluoroprop- 1- enyl)- 2,2- dimethylcyclopropanecarboxylateIBA 01/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2024
1	diazonaphthalenedisulfonic acid (NDS)IBA 10/2023
1	N-nitroso-N-methyltyramine (NNMT)IBA 05/2022
1	Nicotinamide N-MethyltransferaseIBA 05/2022
1	CholesterolIBA 01/2021
1	LipidsIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 11/2020
1	Adenylate KinaseIBA 03/2020
1	Caspase 3 (Caspase-3)IBA 03/2020
1	aminomethylphosphonic acid (AMPA)IBA 01/2020
1	Glyphosate (Roundup)IBA 01/2020
1	Peptide YYIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	MelatoninIBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	decamethrin (deltamethrin)IBA 01/2019
1	phosphatidyl-hydroxytyrosolIBA 10/2018
1	Sweetening Agents (Sweeteners)IBA 06/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2017
1	chloramine-T (Clorina)IBA 08/2017
1	PefloxacinIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2015
1	GlycoconjugatesIBA 03/2014
1	Natamycin (Pimaricin)FDA Link 12/2013
1	difloxacinIBA 02/2011
1	sarafloxacinIBA 02/2011
1	florfenicol amineIBA 11/2008
1	florfenicolIBA 11/2008

Therapy/Procedure

2	Therapeutics 06/2023 - 01/2022
1	Immunomodulation 10/2023
1	Radiotherapy 01/2020